Immix Biopharma (IMMX) Return on Invested Capital (2021 - 2025)

Immix Biopharma has disclosed Return on Invested Capital across 5 years of filings, most recently posting 0.01% for Q4 2025.

• Return on Invested Capital for Q4 2025 came in at 0.01%, up 1.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (up 1.0% YoY), and the FY2025 annual result was 0.01%, up 1.0% from the prior year.
• Return on Invested Capital came in at 0.01% for Q4 2025 at Immix Biopharma, up from 0.04% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2022 to a low of 0.04% in Q3 2025.
• The 5-year median for Return on Invested Capital is 0.01% (2022), against an average of 0.01%.
• Across the five-year window, Return on Invested Capital grew 1 bps in 2024 and slipped 3 bps in 2025, its largest moves.
• Immix Biopharma's Return on Invested Capital stood at 0.0% in 2021, then sank by 140 bps to 0.01% in 2022, then jumped by 56 bps to 0.0% in 2023, then sank by 528 bps to 0.02% in 2024, then surged by 61 bps to 0.01% in 2025.
• The last three Return on Invested Capital figures came in at 0.01% (Q4 2025), 0.04% (Q3 2025), and 0.03% (Q2 2025), per Business Quant data.